Lingshuang Sheng^1,2*, Zixun Yan^1,2*, Li Wang^3*, Wen Wu^1,2*, Yilun Zhang^2,4*, Rong Shen^1,2*, Weiguo Cao^2*, Lei Li^2*, Sheng Chen^2*, Xufeng Jiang^5*, Hongmei Yi^2*, Qi Song^2*, Li Wang^2,6*, Shu Cheng^2,4*, Pengpeng Xu, MD^2,7, Xuanming Yang^8*, Yuxiang Zhu^9*, Xikang Xu^9*, Fuzhe Wang^9*, Jianyong Li, MD¹⁰ and Wei Li Zhao, MD^1,2

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai, China
²Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
³Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁴Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁵Department of Nuclear Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁶Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China
⁷Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁸Shanghai Jiao Tong University, Shanghai, China
⁹Shanghai Longyao Biotechnology Co., Ltd, Shanghai, China
¹⁰Pukou CLL Center, Pukou Division of Jiangsu Province Hospital, Nanjing, China

Joseph P. McGuirk, DO¹, Sunil Abhyankar, MD², Trishna Goswami, MD, MBA³, Mariska ter Haak^4*, Kate Rochlin, PhD^4* and Lawrence S. Lamb, PhD⁵

¹University of Kansas Medical Center, Westwood, KS
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
³IN8bio, Mendham, NJ
⁴IN8bio, New York, NY
⁵IN8bio, Birmingham, AL

Sarah M. Larson, MD¹, Umar Farooq, MD², Boyu Hu, MD³, Tahir Latif, MD⁴, Felix A. Mensah, MD, MBBS^5*, Deepthi Kolli, PhD^6*, Giulia Parisi, PhD^6*, Greg P. Kaufman, MD^6*, Jonathan E. Benjamin, MD, PhD^6* and Akil Merchant, MD⁷

¹Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
²University of Iowa, Iowa City, IA
³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁴University of Cincinnati Medical Center, Cincinnati, OH
⁵Franciscan Health, Indiana Blood and Marrow Transplantation, Indianapolis, IN
⁶ImmPACT Bio, West Hills, CA
⁷Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA

Michael R Bishop, MD¹, Jacalyn Rosenblatt, MD², Binod Dhakal, MBBS³, Noopur Raje⁴, Daniella Cook, BS^5*, Mahmoud R. Gaballa, MD⁶, Estelle Emmanuel-Alejandro, BA^7*, Danielle Nissen, BS^8*, Kamalika Banerjee, MA^9*, Rebecca J Chan, MD, PhD^10*, Ana Kostic, MD^9*, Christopher R. Heery, MD⁹, Tim Welliver, MD, PhD^11*, David Avigan, MD², Andrzej J Jakubowiak, MD, PhD¹² and Matthew Frigault, MD, MS⁷

¹David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Harvard Medical School, Boston, MA
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Massachusetts General Hospital, Boston, MA
⁸Medical College of Wisconsin, Milwaukee, WI
⁹Arcellx, Inc., Redwood City, CA
¹⁰Arcellx, Inc., Burlingame, CA
¹¹800 Bridge Parkway, Arcellx, Inc., Redwood City, CA
¹²Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL

Nelli Bejanyan, MD¹, Hany Elmariah, MD, MS¹, Jongphil Kim, PhD^2*, Cheryl Cox^3*, Melissa Lowden^4*, Xiaofei Song, PhD^2*, Hien Liu, MD⁵, Bin Yu^6*, Kayla Reid, MS^7*, Sean J. Yoder, MS^8*, Christopher Cubitt, PhD^6*, Rawan Faramand, MD⁴, Sayeef Mirza, MD, MPH⁴, Farhad Khimani, MD^1*, Lia Perez, MD^1*, Jose L. Ochoa-Bayona, MD^5*, Justin Boucher, PhD^9*, Jose Alejandro Guevara, PhD^9*, David Sallman, MD¹⁰, Jeffrey E Lancet, MD¹¹, Joseph A. Pidala, MD, PhD¹, Kumar Karyampudi, PhD^3*, Frederick Locke, MD⁴, Claudio Anasetti, MD^4* and Marco Davila, MD, PhD¹²

¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL
⁴Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶Immune Monitoring Core, Moffitt Cancer Center, Tampa, FL
⁷Department of Clinical Science, Moffitt Cancer Center, Tampa, FL
⁸Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁹Immuno-Oncology Program, Moffitt Cancer Center, Tampa, FL
¹⁰Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹²Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Regina M. Myers, MD¹, Yimei Li, PhD^1,2*, Adam Lamble, MD³, Emily M. Hsieh, MD⁴, Samuel John, MD^5*, Gregory Dolan, MD⁶, Hongyan Liu^7*, Lee Chen^4*, Jennifer Sheppard^8*, Amanda M. DiNofia, MD, MSCE^1*, Colleen Annesley, MD^9,10, Stephan A. Grupp, MD, PhD¹, Deepa Bhojwani, MD¹¹, Rebecca A. Gardner, MD^12,13*, Lia Gore, MD¹⁴, Susan R Rheingold, MD¹, Nirali N. Shah, MD¹⁵ and Michael A. Pulsipher, MD¹⁶

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
³Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
⁴Children's Hospital Los Angeles, Los Angeles, CA
⁵Department of Pediatrics, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁶Spencer Fox Eccles School of Medicine at the University of Utah, Division of Hematology and Oncology, Intermountain Primary Children’s Hospital, Salt Lake City, UT
⁷Children's Hospital of Philadelphia, Philadelphia, PA
⁸Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁹Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰Seattle Children's Hospital, Seattle
¹¹Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
¹²Seattle Children's Hospital, Seattle, WA
¹³St. Jude Children's Research Hospital, Memphis, TN
¹⁴Center for Cancer and Blood Disorders, University of Colorado Cancer Center, Aurora, CO
¹⁵Pediatric Oncology Branch, NIH, Bethesda, MD
¹⁶Huntsman Cancer Institute, Salt Lake City, UT

Bhagirathbhai R. Dholaria, MBBS¹, Leyla O. Shune, MD², Mehmet H. Kocoglu, MD³, Andrew Kin, MD⁴, Aravind Ramakrishnan, MD⁵, Ehsan Malek, MD⁶, Siddhartha Ganguly, MD⁷, Christopher Strouse, MD⁸, Jose Carlos Cruz, MD^9*, Edward Anthony Faber, DO, MS^10*, Katherine McArthur^11*, Jeff D Eskew^12*, Joanne McCaigue^12*, Samuel DePrimo, PhD^11*, Chris E Martin, PhD^12*, Sabrina Haag, PhD^13*, Hamid Namini, PhD^14*, Ellen Christie, BS^12*, Rajesh Belani, MD^12*, Syed Rizvi, MD¹⁵, Stacey A Cranert, PhD^12*, Julia Coronella, PhD^12*, Devon J Shedlock, PhD¹² and Caitlin Costello, MD¹⁶

¹Vanderbilt University Medical Center, Nashville, TN
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Westwood, KS
³University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁴Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁵St. David’s South Austin Medical Center, Austin, TX
⁶Roswell Park Comprehensive Cancer Center, Shaker Hts, OH
⁷Houston Methodist Hospital and Neal Cancer Center, Houston, TX
⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁹Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
¹⁰University of Cincinnati, Cincinnati, OH
¹¹Poseida Therapeutics, San Deigo, CA
¹²Poseida Therapeutics, San Diego, CA
¹³Poseida Therapeutics, San Deigo
¹⁴Poseida Therapeutics, San Diego
¹⁵Poseida Therapeutics, Inc., San Diego
¹⁶Moores Cancer Center, University of California, San Diego, San Diego, CA

Armin Ghobadi, MD¹, Joseph P. McGuirk, DO², Paul Shaughnessy, MD³, Constantine S. Tam, MBBS, MD⁴, Melanie Allen, MS^5*, Chenyi Pan, PhD^5*, Ziliang Li, PhD^5*, William N. Stevens, MS^5*, Annie Weaver, PhD^6* and Chan Y. Cheah, MBBS DMSc⁷

¹Division of Oncology, Washington University School of Medicine, St. Louis, MO
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
³Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
⁴Alfred Hospital and Monash University, Melbourne, VIC, Australia
⁵CRISPR Therapeutics, Boston, MA
⁶CRISPR Therapeutics, San Mateo, CA
⁷Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Marco Becilli^1*, Francesca Del Bufalo, MD, PhD^2*, Pietro Merli, MD^2*, Daria Pagliara, MD, PhD^2*, Chiara Rosignoli, MD^2*, Valentina Bertaina, PhD^2*, Giuseppina Li Pira, PhD^2*, Maria Giuseppina Cefalo, MD^2*, Monica Gunetti, PhD^3*, Stefano Iacovelli, PhD^3*, Emilia Boccieri, MD^2*, Matilde Sinibaldi, PhD^2*, Yunqin Lee, PhD^4*, Concetta Quintarelli, PhD^5*, Dario Campana, MD, PhD^4,6 and Franco Locatelli, MD^2,7

¹Department of Hematology-Oncology and Cell and Gene Therapy, Bambino Gesù Children' Hospital, Rome, Italy
²Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
³Officina Farmaceutica, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
⁴MediSix Therapeutics, Singapore, Singapore
⁵IRCCS Bambino Gesù Children's Hospital, Rome, Italy
⁶National University of Singapore, Singapore, SGP
⁷Catholic University of the Sacred Heart, Rome, Italy

Xiangyu Zhao, MD, PhD¹, Meng Lv, MD, PhD², Yu Wang^2*, Yi-Yang Ding^2*, Zhixiao Zhou^3*, Jiasheng Wang, MD⁴, HongLi Zheng^5*, Xueqiang Zhao^5*, Xin Lin, PhD^3* and Xiao Jun Huang, MD²

¹Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
²Peking University People's Hospital, Beijing, China
³Tsinghua University School of Medicine, Beijing, China
⁴Changping Laboratory, Beijing, China
⁵Bristar Immunotech Limited, Beijing, China

Andrew J Portuguese, MD¹, Sherilyn A. Tuazon, MD^2*, Margot J. Pont^3*, Gabriel Cole^4*, Blythe Duke Sather, PhD^5*, Xiaoling Song^6*, Brent L. Wood, MD, PhD⁷, Michelle Lee Blake, PhD^8*, Melissa Works, PhD^9*, Mazyar Shadman, MD, MPH¹⁰, Qian Vicky Wu^6*, Jenna M. Voutsinas, MPH^11*, Ted Gooley, PhD^12*, Cameron J. Turtle, MBBS, PhD^13*, Brian G. Till, MD¹⁴, David G. Coffey, MD¹⁵, David G. Maloney, MD, PhD⁶, Edward Libby, MD⁶, Aude G Chapuis, MD⁶, Filippo Milano, MD¹⁰, Stanley R. Riddell, MD¹⁶, Andrew J. Cowan, MD⁶ and Damian J. Green, MD¹⁷

¹University of Washington Fred Hutchinson Cancer Center, Seattle, WA
²Bristol Myers Squibb, Seattle, WA
³Galapagos BV, Oegstgeest, Netherlands
⁴CellPoint Bio, Oegstgeest, WA, Netherlands
⁵Tune Therapeutics, Durham, NC
⁶Fred Hutchinson Cancer Center, Seattle, WA
⁷Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
⁸Sonoma Biotherapeutics, Sonoma, CA
⁹Shape Therapeutics, Seattle, WA
¹⁰Fred Hutchinson Cancer Research Center, Seattle, WA
¹¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹²University of Washington, Seattle, WA
¹³University of Sydney, Sydney, NSW, Australia
¹⁴Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
¹⁵Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
¹⁶Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
¹⁷Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL

Roman M. Shapiro, MD¹, Haesook T. Kim, PhD¹, William H Terral^2*, Vincent T. Ho, MD^3*, Mahasweta Gooptu, MD⁴, Rizwan Romee, MD¹, Christopher J. Gibson, MD⁵, Amar H. Kelkar, MD, MPH, FACP³, Corey S. Cutler, MD, MPH³, Joseph H. Antin, MD¹, Katie Maurer, MD, PhD³, Catherine J. Wu, MD^3*, Robert Zeiser, MD⁶, Jerome Ritz, MD³, Robert J. Soiffer, MD⁷, Sarah Nikiforow, MD, PhD¹ and John Koreth, MD, MBBS, PhD, DPhil¹

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
⁶University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
⁷Dana-Farber Cancer Inst., Boston, MA

Francesca Del Bufalo, MD, PhD^1*, Mattia Algeri, MD^1,2*, Daria Pagliara, MD, PhD^1*, Linda Hanssens^3*, Valentina Bertaina, PhD^1*, Monica Gunetti, PhD^4*, Giuseppina Li Pira, PhD^1*, Chiara Rosignoli, MD^1*, Michele Massa^1*, Matilde Sinibaldi, PhD^1*, Giovanna Leone^5*, Marco Becilli^6*, Biagio De Angelis, PhD^1*, Concetta Quintarelli, PhD^7* and Franco Locatelli, MD^1,8

¹Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
²Department of Medical of Health Sciencies,, Magna Grecia University of Catanzaro, Catanzaro, Italy, Catanzaro, Italy
³Miltenyi Biomedicine, Bergisch Gladbach, Germany
⁴Officina Farmaceutica, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
⁵IRCCS Bambino Gesù Children Hospital, Rome, ITA
⁶Department of Hematology-Oncology and Cell and Gene Therapy, Bambino Gesù Children' Hospital, Rome, Italy
⁷IRCCS Bambino Gesù Children's Hospital, Rome, Italy
⁸Catholic University of the Sacred Heart, Rome, Italy

Nora Rebecca Schwingen^1*, Fabian Mueller, MD^2,3,4, Julia Katharina Scholz, MD^5*, Michael Aigner, PhD^2,4,6*, Melanie Hagen, MD^2,7*, Andreas Wirsching, MD^2,7*, Jule Taubmann, MD^2,7*, Sascha Kretschmann, PhD^2,4,6*, Soraya Kharboutli, MD^4*, Tobias Krickau, MD^8*, Nora Naumann-Bartsch, MD^9*, Giulia Benintende^1*, Silvia Spoerl, MD^4*, Ingrid Vasova, MD^1*, Tobias Rothe, PhD^2,7*, Heiko Bruns, PhD^2,6*, Ricardo Grieshaber-Bouyer, MD, PhD^2,10*, Frederik Graw, PhD^2,6,11*, Markus Metzler, MD, PhD^8*, Georg Schett, MD^2,10*, Andreas Mackensen, MD^2,4,6* and Simon Voelkl, PhD^2,5,6*

¹Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
²Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
³Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
⁴Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
⁵Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
⁶Bavarian Cancer Research Center (BZKF), Erlangen, Germany
⁷Department of Internal Medicine 3 - Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany
⁸Department of Pediatrics, University Hospital of Erlangen, Erlangen, Germany
⁹Department of Pediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
¹⁰Department of Internal Medicine 3 – Rheumatology, University Hospital of Erlangen, Erlangen, Germany
¹¹Department of Internal Medicine 5, Hematology and Oncology, Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany

Jia Yin^1*, Qingya Cui^1*, Haiping Dai^2*, Zheng Li, MD^1*, Liqing Kang^3*, Wei Cui^1*, Xiaopeng Tian^1*, Xiaming Zhu^1*, Lei Yu^3*, Depei Wu, MD, PhD¹ and Xiaowen Tang^1*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
³Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China

Bijal D Shah, MD¹, Jeremy Pantin, MD^2*, Karamjeet S Sandhu, MD³, Elias Jabbour, MD⁴, Jae H. Park, MD⁵, Paul Shaughnessy, MD⁶, Mehrdad Abedi, MD^7*, Michael R Bishop, MD⁸, Daniel J. DeAngelo, MD, PhD⁹, Wolfram Brugger, MD^10*, Martin Brown, MSc^11*, Dilip Patel, BSc^11*, Claire Roddie, MD^12* and Aaron C. Logan, MD, PhD¹³

¹Moffitt Cancer Center, Tampa, FL
²Sarah Cannon Transplant and Cellular Therapy Program, Nashville, TN
³City of Hope National Medical Center, Duarte, CA
⁴University of Texas MD Anderson Cancer Center, Houston, TX
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
⁷University of California Davis, Davis, CA
⁸The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Autolus Therapeutics, Munich, Germany
¹¹Autolus Therapeutics, London, United Kingdom
¹²University College London Cancer Institute, London, United Kingdom
¹³Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA

Caroline Diorio, MD¹, Paul Shaughnessy, MD², Nosha Farhadfar, MD^2*, Anjali S. Advani, MD³, Wen-Kai Weng, MD, PhD⁴, Hagop Youssoufian, MD^5*, Guo Chen, PhD^5*, Felicia Nguyen Brown, MS^5*, Bahru Habtermariam, PharmD^5*, Lalit Kumar, PhD^5*, Jigar Patel^5*, Shangbin (Gary) Liu, PhD^5*, Sunita Goyal, MD^5*, Amy Simon, MD^5*, Alex C. Minella, MD⁵ and David T. Teachey, MD¹

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
³Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁴Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Beam Therapeutics Inc., Cambridge, MA

Antonio Di Stasi, MD^*, Sean Patrick Bliven, MD, Lauren Kelly Shea, MD, MS, Maureen Boms^*, Amber McKell^*, Rachael Shevin^*, Amitkumar N. Mehta, MD and Mayur S. Narkhede, MD

O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

Zihao Wang^1,2*, Chong-Sheng Qian^2,3*, Yan Qiu^4*, Hai-xia Zhou^2,3*, Mingzhu Xu^2,5*, Li-Qing Kang^6*, Ai-Ning Sun^2,3*, Depei Wu, MD, PhD^2,7, Lei Yu^6* and Sheng-Li Xue^2,8*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, CA, China
²Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
³National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁴The First People’s Hospital of Changzhou, Changzhou, China
⁵The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
⁶Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
⁷Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁸Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China

Jeremy Ramdial, MD¹, Lorlyn Clemente^1*, Pinaki Banerjee, PhD^1*, Bouthaina S. Dabaja, MD^2*, Gheath Al-Atrash, MD, PhD^1*, Amin M. Alousi, MD^1*, Betul Oran, MD, MS¹, Uday Popat, MD¹, Jin S. Im, MD, PhD¹, Samer A. Srour, MD¹, George Chen, MD¹, Partow Kebriaei, MD¹, Chitra Hosing, MD¹, David Marin, MD¹, Katayoun Rezvani, MD, PhD¹, Elizabeth J. Shpall, MD¹ and Richard E. Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX

Fang Liu^1*, Yu MA, MD^2*, Yecheng LI, MD^3*, Kevin G. Pinz^4*, Xiao Wang, MD^5*, Masayuki Wada^6* and Yupo Ma, MD, PhD^4,7*

¹Hematology department, Chengdu BOE hospital, Chengdu, Sichuan, China
²Manufactory Division, Icar Bio Therapeutics Ltd, ZHONGSHAN, GUANGDONG, China
³hematology department, Chengdu BOE hospital, Chengdu, Sichuan, China
⁴Research & Development Division, Icell Gene Therapeutics Inc, Stony Brook, NY
⁵Hematology department, Chengdu military general hospital, Chengdu, Sichuan, China
⁶Icell Gene Therapeutics INC, Stony Brook, NY
⁷Manufactory Division, iCAR Bio Therapeutics Ltd,, China, Zhongshan, guangdong, China

Chengcheng Fu^1*, Lingzhi Yan^1*, Weiqin Yao^1*, Jingjing Shang^1*, Song Jin^1*, Shuang Yan^1*, Fang Tang^1*, Ziling Zhu^1*, Depei Wu, MD, PhD², Ying Li^3*, Nishanthan Rajakumaraswamy^3*, Wei Zheng^3*, Hua Jiang^3*, Zhaohui Liao^3* and Zonghai Li^3*

¹The First Affiliated Hospital of Soochow University, Suzhou, China
²Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
³CARsgen Therapeutics Co. Ltd., Shanghai, China

Srinishant Rajarajan, MBBS¹, Kalaivani Babu, MBBS¹, Adanma Anji Ayanambakkam Attanathi, MD^2*, Asmi Chattaraj³, Sruthi P Ramanan, MBBS⁴, Nithya Ramesh, MD³, Arya Mariam Roy, MD⁵ and Amit Correa, MD^6*

¹Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
²Oklahoma University Health Sciences, Oklahoma City, OK
³Allegheny General Hospital, Pittsburgh, PA
⁴Allegheny General hospital, Pittsburgh, PA
⁵Rosewell Park Cancer Center, Buffalo, NY
⁶Memorial Hermann, McGovern Medical School, Houston

Claire Roddie, MD^1*, Jae H. Park, MD², Paul Shaughnessy, MD³, Aaron C. Logan, MD, PhD⁴, Karamjeet S Sandhu, MD⁵, Mehrdad Abedi, MD^6*, Bijal D Shah, MD⁷, Michael R Bishop, MD^8*, Daniel J. DeAngelo, MD, PhD⁹, Wolfram Brugger, MD^10*, Martin A Pule, MD^11*, Justin Shang, PhD^12* and Elias Jabbour, MD¹³

¹University College London Cancer Institute, London, United Kingdom
²Memorial Sloan Kettering Cancer Center, New York, NY
³Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
⁴Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA
⁵City of Hope National Medical Center, Duarte, CA
⁶University of California Davis, Davis, CA
⁷Moffitt Cancer Center, Tampa, FL
⁸The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Autolus Therapeutics, Munich, Germany
¹¹Autolus Therapeutics, London, United Kingdom
¹²Autolus Therapeutics, Rockville, MD
¹³University of Texas MD Anderson Cancer Center, Houston, TX

Hitomi Hosoya, MD, PhD¹, Sebastian Fernandez-Pol, MD, PhD^2*, John Gubatan, MD^3*, Zachary Ehlinger, MS^4*, Claire Lohman^5*, Armando N Bastidas Torres^6*, Safa Najidh, MD^6*, Alexa Kwang, BSc^7*, George Duran^7*, Charles Wright III^8*, Vanessa E. Kennedy, MD¹, Sushma Bharadwaj, MD¹, Melody Smith, MD, MS⁹, Saurabh Dahiya, MD¹, Matthew J. Frank, MD, PhD⁴, Lori Muffly, MD⁹, Wen-Kai Weng, MD, PhD¹, Bita Sahaf^10*, David Kurtz, MD, PhD¹¹, Crystal L. Mackall, MD¹², Michael S. Khodadoust, MD, PhD¹³, David B. Miklos, MD, PhD¹⁴, Surbhi Sidana, MD⁹ and Lekha Mikkilineni, MD, MA¹⁵

¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
²Department of Pathology, Stanford University, Palo Alto
³Division of Gastroenterology and Hepatology, Stanford University, Palo Alto
⁴Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
⁵Cancer Correlative Science Unit, Stanford Cancer Institute, Palo Alto, CA
⁶Division of Oncology, Stanford University, Palo Alto
⁷Department of Medicine (Oncology), Stanford University, Palo Alto, CA
⁸Stanford University School of Medicine, Palo Alto
⁹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
¹⁰Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
¹¹Division of Oncology, Department of Medicine, Stanford University, Stanford, CA
¹²Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
¹³Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA
¹⁴Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University, Stanford, CA
¹⁵Division of Blood and Marrow Transplant and Cellular Therapy, Stanford University, Palo Alto, CA

Anca Askanase, MD, MPH^1*, Leila Khalili, NP^1*, Cornell Chang, BA^2*, Alison Blaus, BS^2*, Phung Gip, PhD^2*, Elaine Karis, MD^2* and David Shook, MD²

¹Columbia University Irving Medical Center, New York, NY
²Nkarta, South San Francisco, CA